1- Expression and prognostic value of ING3 in advanced laryngeal squamous cell carcinoma
BARLAK NESLİŞAH, Kuşdemir Gülnur, Gümüş Rasim, ŞAHİN ABDULKADİR, GÜNDOĞDU BETÜL, KARATAŞ ÖMER FARUK, TATAR ARZU, Yayın Yeri:The European Research Journal ,2023 2023

2- AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer
AYTATLI ABDULMELİK, BARLAK NESLİŞAH, Sanli Fatma, ÇAĞLAR HASAN ONUR, GÜNDOĞDU BETÜL, TATAR ARZU, Ittmann Mıchael, KARATAŞ ÖMER FARUK, Yayın Yeri:CELLULAR ONCOLOGY ,2022 2022

3- MicroRNA145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells
BARLAK NESLİŞAH, Capik Ozel, Kilic Ahsen, Sanli Fatma, AYTATLI ABDULMELİK, YAZICI AYŞENUR, AYDIN KARATAŞ ELANUR, ÖRTÜCÜ SERKAN, KARATAŞ ÖMER FARUK, Yayın Yeri:Cell Biology International ,2021 2021

4- MiR-4484 Acts as a Potential Saliva Biomarker for Early Detection of Peri-implantitis
URVASIZOĞLU GELENGÜL, Kilic Ahsen, BARLAK NESLİŞAH, GÜNDOĞDU MUSTAFA, KARATAŞ ÖMER FARUK, Yayın Yeri:INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS ,2021 2021

5- The effects of Daucus carota extract against PC3, PNT1a prostate cells, acetylcholinesterase, glutathione S-transferase, and α-glycosidase; an in vitro-in silico study
ATALAR MEHMET NURİ, ARAS ABDÜLMELİK, TÜRKAN FİKRET, BARLAK NESLİŞAH, YILDIKO ÜMİT, KARATAŞ ÖMER FARUK, ALMA MEHMET HAKKI, Yayın Yeri:Journal of Food Biochemistry ,2021 2021

6- Comprehensive in silico analysis for identification of novel candidate target genes, including DHX36, OPA1, and SENP2, located on chromosome 3q in head and neck cancers
KARATAŞ ÖMER FARUK, Capik Ozel, BARLAK NESLİŞAH, AYDIN KARATAŞ ELANUR, Yayın Yeri:Head & Neck ,2021 2021

7- The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells
Sanli Fatma, BARLAK NESLİŞAH, Kilic Ahsen, Capik Ozel, AYTATLI ABDULMELİK, KARATAŞ ÖMER FARUK, Yayın Yeri:The European Research Journal ,2020 2020

8- The roles of microRNAs in the stemness of oral cancer cells
BARLAK NESLİŞAH, Capik Ozel, Sanli Fatma, KARATAŞ ÖMER FARUK, Yayın Yeri:Oral Oncology ,2020 2020

9- Mode of action of carboplatin via activating p53/miR\u2010145 axis in head and neck cancers
Kilic Ahsen, BARLAK NESLİŞAH, Sanli Fatma, AYTATLI ABDULMELİK, Capik Ozel, KARATAŞ ÖMER FARUK, Yayın Yeri:The Laryngoscope ,2020 2020

10- Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep- 2 to 5-Fluorouracil
BARLAK NESLİŞAH, Sanli Fatma, Capik Ozel, TUYSUZ ELANUR, AYDIN KARATAŞ ELANUR, TÜRKEZ HASAN, KARATAŞ ÖMER FARUK, Yayın Yeri:Clinical Cancer Drugs ,2019 2019

11- ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer
BARLAK NESLİŞAH, Capik Ozel, Sanli Fatma, Kilic Ahsen, AYTATLI ABDULMELİK, YAZICI AYŞENUR, ÖRTÜCÜ SERKAN, Ittmann Mıchael, KARATAŞ ÖMER FARUK, Yayın Yeri:Cell Biology International ,2019 2019

12- Current cancer stem cell biomarkers in laryngeal cancer
KARATAŞ ÖMER FARUK, BARLAK NESLİŞAH, Sahin Huseyin, Aydin Hatice, Yayın Yeri:The European Research Journal ,2017 2017